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advisories and travel health precautions 
were subsequently released, including 
those from Canada and United 
States (9,10). These precautions 
recommended that preventative 
measures such as vaccination and safe 
food and water consumption practices 
be adhered to by residents and visitors 
to affected regions. Although the 
public health community anticipated 
that travel-associated cases would 
be diagnosed in Québec, this report 
of a documented case (supported 
by laboratory and epidemiologic 
data) emphasizes the domestic and 
international public health risk caused 
by the nationwide outbreak in Haiti. It 
also illustrates the need for an accurate 
travel history in clinical and laboratory 
diagnosis of cholera infections.
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Easy Diagnosis 
of Invasive 
Pneumococcal 
Disease
To the Editor: Invasive 
pneumococcal disease (IPD) causes 
many cases of severe disease and 
death among children <5 years of 
age, mostly in developing countries 
(1,2). Before conjugate vaccines 
can be introduced in developing 
countries, information about disease 
epidemiology is urgently needed. 
The lack of laboratories equipped to 
perform pneumococcal serotyping 
leads to the need to send isolates to 
reference laboratories. Good sample 
preservation is necessary to prevent 
samples from arriving at the laboratory 
in poor condition. We evaluated the 
usefulness of multiplex real-time PCR 
from strains and blood samples kept at 
room temperature on dried blood spot 
(DBS)  ﬁ  lter paper for detecting and 
serotyping Streptococcus pneumoniae.  
DBS screening is a reliable method 
that requires only a small amount of 
blood; it is used for the diagnosis of 
several human diseases (3,4). 
To validate the technique, we 
selected 15 pneumococcus clinical 
isolates representing 15 serotypes (1, 
5, 19A, 19F, 14, 3, 7F, 4, 6A, 6B, 8, 
9N, 18C, 23A, 23F) obtained during 
2009 from patients at Hospital Sant 
Joan de Déu, in Barcelona. These 
isolates, used as controls, had been 
serotyped by quellung reaction at 
the Instituto de Salud Carlos III, 
Majadahonda-Madrid, Spain. These 
strains were cultured overnight 
at 35°C in 5% carbon dioxide on 
Columbia agar plates with 5% sheep 
blood (bioMérieux SA, Marcy 
l’Etoile, France). A suspension of 
each strain was adjusted to match a 
0.5 McFarland standard (equivalent to 
108 colony-forming units (CFU)/mL). 
Stock solutions of pneumococcus 
culture for each previously identiﬁ  ed 
serotype were injected into blood 
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previously extracted from 2 healthy 
volunteers. Serial dilutions of 100,000 
CFU/mL to 1,000 CFU/mL (1,000 
to 10 CFU equivalents/PCR) were 
performed. A total of 100 μL of blood 
was applied to DBS ﬁ  lter paper, and 
another 100 μL was used for DNA 
extraction from fresh blood. All DBS 
samples were air dried for 1 week. 
The procedure was also performed on 
negative control blood samples.
DNA was extracted from DBS 
and fresh blood samples by using 
the NucliSense easyMAG automated 
extraction platform (bioMérieux, 
Boxtel, the Netherlands) according to 
the manufacturer’s instructions. DNA 
detection of the pneumolysin  (ply) 
gene by real-time PCR was performed 
according to a published assay (5). In 
addition, we performed a multiplex 
real-time PCR for molecular serotype 
detection of serotypes 1, 3, 5, 4, 
6A, 6B, 7FA, 8, 9VANL, 14, 15BC, 
18CB, 19A, 19FBC, 23F, 23A and 
the conserved capsular gene wzg as 
described by Tarrago et al. (6). DNA 
extracts were ampliﬁ   ed with the 
Applied Biosystems 7300 Real-time 
PCR System (Applied Biosystems, 
Foster City, CA, USA). Negative 
results were deﬁ   ned as those with 
cycle threshold >40.
To evaluate the reliability 
obtained with this in vivo approach, 
we performed identiﬁ  cation  and 
serotyping of S. pneumoniae in 
25 DBS samples from 25 children 
at Saint John of God Hospital in 
Mabesseneh-Lunsar, Sierra Leone. 
This hospital does not perform blood 
cultures. IPD was conﬁ  rmed  when 
DNA of a pneumolysin (ply) gene 
and an additional capsular gene of 
S. pneumoniae were detected by 
multiplex real-time PCR of DBS 
samples. 
Detection of ply,  wzg, and the 
speciﬁ  c gene for molecular serotype 
showed that both fresh blood and DBS 
samples yielded correctly positive 
results from the 10-fold serial dilutions 
analyzed (Table). With respect to the 
25 (11 female and 14 male) patients 
from Sierra Leone who had suspected 
IPD, the median age was 25.71 months 
(range 15 days to 96 months); all had 
a diagnosis of fever without apparent 
source, and 16 also had malaria. 
Of these 25 children, DBS samples 
from 15 (60%) yielded a positive 
result for the ply and wzg genes, 
so they were considered conﬁ  rmed 
episodes of IPD. A serotype included 
in 13-valent conjugate vaccine was 
detected in 6 (40%) of 15 positive 
samples: serotypes 3, 7FA, 19A, 6A, 
6B, and 9VNL (1 sample each). In the 
remaining 9 samples, the results for 
ply gene and wzg gene were positive, 
but none of the 24 tested serotypes 
was detected.
This preliminary study enabled 
us to demonstrate that DBS screening 
is a reliable and easy method 
for diagnosing IPD and also for 
epidemiologic surveillance of the 
more frequent serotypes. The main 
limitation of our study is the small 
number of DBS samples sent from 
Saint John of God Hospital in Sierra 
Leone.
In conclusion, the DBS technique 
enables reproducible transport of 
samples for identiﬁ  cation  and 
serotyping of S. pneumoniae by 
multiplex PCR. The use of DBS on 
ﬁ  lter paper is an attractive alternative 
method for storing samples at room 
temperature and easily transporting 
them. Additional studies, including 
evaluation of the relative sensitivity 
of this method compared to direct 
culture, are necessary.
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Table. Sensitivity of real-time PCR for detecting Streptococcus pneumoniae ply or wzg 
genes or a specific gene for molecular serotype from fresh or dried blood spot samples*
Gene or serotype
Serial dilutions correctly detected, CFU equivalent/PCR† 
Fresh blood  Dried blood spot 
ply gene  1.10
1–1.10
3 1.10
1–1.10
3
wzg gene  1.10
1–1.10
3 1.10
1–1.10
3
Serotype 1  1.10
1–1.10
3 1.10
1–1.10
3
Serotype 5  1.10
1–1.10
3 1.10
1–1.10
3
Serotype 19A  1.10
1–1.10
3 1.10
1–1.10
3
Serotype 19F  1.10
1–1.10
3 1.10
1–1.10
3
Serotype 14  1.10
1–1.10
3 1.10
1–1.10
3
Serotype 3  1.10
2–1.10
3 1.10
1–1.10
3
Serotype 7F  1.10
1–1.10
3 1.10
1–1.10
3
Serotype 4  1.10
1–1.10
3 1.10
1–1.10
3
Serotype 6A  1.10
1–1.10
3 1.10
2–1.10
3
Serotype 6B  1.10
1–1.10
3 1.10
1–1.10
3
Serotype 8  1.10
1–1.10
3 1.10
2–1.10
3
Serotype 9N  1.10
1–1.10
3 1.10
1–1.10
3
Serotype 18C  1.10
1–1.10
3 1.10
1–1.10
3
Serotype 23A  1.10
1–1.10
3 1.10
1–1.10
3
Serotype 23F  1.10
1–1.10
3 1.10
1–1.10
3
*Serial dilutions (10–1,000 CFU equivalent/PCR) of 15 pneumococcus cultures mixed with 15 
negative-control blood samples were analyzed. Boldface indicates results that differ from others. 
†10 CFU equivalent/PCR = 1,000 CFU equivalents/mL blood. LETTERS
DOI: 10.3201/eid1706.100997
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Mimivirus-like 
Particles in 
Acanthamoebae 
from Sewage 
Sludge
To the Editor: Mimivirus is a 
giant, double-stranded DNA virus. Its 
650-nm diameter and 1.2-Mb genome 
make it the largest known virus (1). 
In 2003, mimivirus was isolated from 
a water cooling tower in Bradford, 
UK, after a pneumonia outbreak and 
was reported to infect Acanthamoeba 
polyphaga amebae (2). Subsequently, 
a small number of additional isolates 
have been reported (3).  
Mimivirus has been associated 
with pneumonia, and this association 
was strengthened after antibodies 
to mimivirus were found in 
serum samples from patients with 
community- and hospital-acquired 
pneumonia and after mimivirus DNA 
was found in bronchoalveolar lavage 
specimens (4). More direct evidence 
of pathogenicity was illustrated when 
a pneumonia-like disease developed 
in a laboratory technician who 
worked with mimivirus and showed 
seroconversion to 23 mimivirus-
speciﬁ  c proteins (5).
We report ﬁ  nding  mimivirus-
like particles during our molecular 
study of Acanthamoeba spp. 
abundance and diversity in ﬁ  nal-
stage conventionally treated sewage 
sludge from a wastewater treatment 
plant in the West Midlands, UK. 
Using metagenomic DNA extracted 
from the sludge (6), we estimated 
the abundance of Acanthamoeba 
spp. by using real-time PCR (7) and 
found it to be ≈1 × 102/g sludge. To 
assess species diversity, we ampliﬁ  ed 
an  Acanthamoeba spp.–speciﬁ  c 
18S rRNA target, which resulted in 
products of ≈450 bp (8). PCR products 
were cloned and sequenced, revealing 
low  Acanthamoeba spp. diversity 
with a predominance of clones most 
similar to A. palestinensis (22/25 
clones), which fall within the T6 
clade according to the classiﬁ  cation 
of Stothard et al. (9). A small number 
(3/25) of clones showed closest 
similarity to acanthamoebae belonging 
to the T4 clade, which includes strains 
considered to be human pathogens, 
including some A. polyphaga strains.
Acanthamoebae were isolated 
from fully digested sewage sludge 
by inoculating diluted sludge onto 
cerophyl-Prescott infusion agar 
and subculturing onto nonnutrient 
agar plates streaked with heat-
killed  Escherichia coli. Cultures 
were incubated at 20°C and 30°C 
and examined under an Axioskop 
2 microscope (Zeiss, Oberkochen, 
Germany) at 100× magniﬁ  cation; cells 
of interest were examined at 1,000× 
magniﬁ  cation. One clonal population 
of an Acanthamoeba sp. isolated at 
20°C, which demonstrated typical 
trophozoite and cyst morphology, 
contained large numbers of particles 
either within vacuoles or within the 
cytoplasm (Figure). Vacuoles were 
densely packed with particles that 
appeared to be constantly moving; 
vacuole size varied from that typical 
of food vacuoles to large vacuoles 
that occupied most of the cell volume 
(expanded online Figure, panels B, 
D, and G, www.cdc.gov/EID/content/
17/6/1127-F.htm). Because the par-
ticles were assumed to be bacterial 
pathogens, efforts were made to 
produce an axenic culture of the ameba 
isolate, and 16S rRNA PCR was 
performed to identify any intracellular 
bacteria. DNA was extracted by using 
a phenol chloroform method according 
to Grifﬁ  ths et al. (6). However, no 16S 
rRNA PCR products were ampliﬁ  ed. 
Months later, an image review led 
to recognition of unusual arrangements 
of intracellular particles in a lattice-like 
structure in which each particle was 
surrounded by 6 others. Measurement 
of rows of particles, assuming tight 
packing, gave an average particle size 
of 620 nm. At this point, we realized 
that the particles were virus-like 
  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 17, No. 6, June 2011  1127